Search
-
News
Gift from Jamie C. Nicholls and O. Francis Biondi will support MSK’s commitment to disparities research, expanded access to cancer care for underserved communities, and training diverse leaders in oncology.
… Monday, February 8, 2021 Memorial Sloan Kettering Cancer Center (MSK) today announced the newly established Nicholls-Biondi Chair for Health Equity . This permanently endowed chair is dedicated to improving outcomes for patients from medically underserved communities and building a base of knowledge
-
News
Because people with cancer have a higher-than-normal risk of developing infections, our infection control experts have developed a number of innovative programs.
… Tuesday, October 18, 2016 Summary Because cancer treatments can weaken the immune system, infections are a common complication during cancer treatment. MSK has implemented a number of programs to protect patients from infections. One of the biggest complications for people receiving chemotherapy , especially
-
News
This story answers common questions about how your gut microbiota impacts your health, how to protect it, and the impact it has on diseases like cancer.
… Thursday, June 8, 2023 You may have heard the terms “gut microbiota” and “microbiome” and wondered what they mean and why they matter. Many researchers at Memorial Sloan Kettering Cancer Center (MSK) are studying how they influence the health of people with cancer and the general population, too. Here
-
News
Proton therapy offers a way to treat pediatric cancers more safely.
… Tuesday, June 18, 2019 Summary Children are especially sensitive to the side effects of conventional radiation therapy. For some pediatric cancers, proton therapy can be used to destroy tumors while minimizing risks. Radiation therapy is quite effective at shrinking or eliminating tumors. But doctors
-
MSK News
Learn how MSK helped a man with stage 4 stomach (gastric) cancer using checkpoint inhibitors, a type of immunotherapy that also treats many other cancers.
… Thursday, July 3, 2025 Antonio Lekhrajmal knew his diagnosis of advanced stomach cancer — also called gastric cancer — was extremely serious. He credits his doctor, Memorial Sloan Kettering Cancer Center (MSK) gastrointestinal oncologist Yelena Janjigian, MD , with being upfront with him, and treating
-
News
Physicians and scientists from MSK presented advances in transplantation and cellular therapies at the Tandem Meetings, a joint event hosted by the American Society for Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research.
… Tuesday, February 25, 2025 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) presented advances in transplantation and cellular therapies at the Tandem Meetings, a joint event hosted by the American Society for Transplantation and Cellular Therapy and the Center for International
-
News
Chris Lee’s story begins in the 1940s, when his maternal grandfather boarded a ship in China headed to America.
… Friday, May 27, 2022 Chris Lee’s story begins in the 1940s, when his maternal grandfather boarded a ship in China headed to America. Like tens of millions of immigrants, Mr. Wong entered the U.S. via Ellis Island Immigration Station, with the “hopes of making a better life for his family and their future
-
News
A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.
… Friday, February 29, 2008 A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia. The protein, called AML1, plays a critical role in the
-
News
In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care.
… Saturday, December 6, 2014 In a late-stage clinical trial, Hodgkin lymphoma (HL) patients who received brentuximab vedotin (BV) post-transplant lived longer without disease progression than patients who received only supportive care. This is the first time a study has demonstrated that adding a maintenance
-
News
Learn what detection of the polio virus in New York State means for you.
… Monday, September 12, 2022 Polio has been in the news after the poliovirus was detected in wastewater samples of several New York counties — including New York City — and a person was identified as having the disease by New York health officials in July. On September 9, Gov. Kathy Hochul declared a state